ÂÜÀòÂÒÂ×

Andrew Sutton, MBA, currently serves as Sr. Director of Business Development at Inato, where significant achievements in 2023 include acquiring three Top 10 Pharma clients, one Top 20 Pharma client, and two mid-market clients. Prior experience includes a tenure at ClinOne, where Sutton was recognized as the top bookings performer in 2022, acquiring nine new customers and expanding services among existing clients. Sutton's earlier roles at Greenphire culminated in a successful exit to private equity, highlighting expertise in clinical payment technology solutions. Sutton holds an MBA from Monmouth University, where a concentration in Management and Marketing was pursued, along with a Bachelor of Science in Business Administration.